Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | PHGDH | O43175 | 1/20 | 0.31 |
| ▸ | MGLL | Q99685 | 1/20 | 0.31 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.30 |
| ▸ | HTR6 | P50406 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL920451 | 0.92 | KMT2A (0.31) | MEN1KMT2APHGDHMGLL | |
| SCHEMBL9059294 | 0.70 | — | — | |
| SCHEMBL8789877 | 0.67 | — | — | |
| SCHEMBL5246612 | 0.67 | HTR6 (0.33) | HTR6 | |
| SCHEMBL8788678 | 0.67 | — | — | |
| SCHEMBL9044554 | 0.67 | — | — | |
| SCHEMBL24302231 | 0.65 | PHGDH (0.56) | MEN1KMT2APHGDHMGLLSLC18A3 | |
| SCHEMBL5784736 | 0.65 | PHGDH (0.56) | MEN1KMT2APHGDHMGLLSLC18A3 | |
| SCHEMBL584039 | 0.65 | — | — | |
| SCHEMBL6245189 | 0.65 | PHGDH (0.56) | MEN1KMT2APHGDHMGLLSLC18A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3135681-B1 | RUTHENIUM COMPLEX, METHOD FOR PRODUCING SAME, AND USE OF SAME | TAKASAGO PERFUMERY CO LTD (JP) | 2020-08-19 | — | — | EP | claimed |
| US-10744494-B2 | Immobilized metal alkylidene catalysts and use thereof in olefin metathesis | XIMO AG (CH) | 2020-08-18 | — | — | US | claimed |
| EP-3394074-B1 | IMMOBILIZED METAL ALKYLIDENE CATALYSTS AND USE THEREOF IN OLEFIN METATHESIS | XIMO AG (CH) | 2019-10-09 | — | — | EP | claimed |
| US-20190001315-A1 | IMMOBILIZED METAL ALKYLIDENE CATALYSTS AND USE THEREOF IN OLEFIN METATHESIS | KiMo AG (CH) | 2019-01-03 | — | — | US | claimed |
| US-7268233-B2 | Nickel-carbene, palladium-carbene and platinum-carbene complexes, their production and use in catalytic reactions | UMICORE AG & CO. KG (DE) | 2007-09-11 | — | — | US | claimed |
| EP-1526917-B1 | NOVEL NICKEL-CARBENE, PALLADIUM-CARBENE AND PLATINUM-CARBENE COMPLEXES, THEIR PRODUCTION AND USE IN CATALYTIC REACTIONS | UMICORE AG & CO KG (DE) | 2007-03-14 | — | — | EP | claimed |
| US-20060122398-A1 | Novel nickel-carbene, palladium-carbene and platinum-carbene complexes, their produciton and use in catalytic reactions | UMICORE AG & CO. KG (DE) | 2006-06-08 | — | — | US | claimed |
| WO-2024085043-A1 | CATALYST LIQUID AND POLYMERIZABLE COMPOSITION | RIMTEC株式会社 | 2024-04-25 | — | — | WO | disclosed |
| WO-2024085044-A1 | POLYMERIZABLE COMPOSITION AND NORBORNENE RESIN | RIMTEC株式会社 | 2024-04-25 | — | — | WO | disclosed |
| CN-109563242-B | Method for producing polymer compound | 住友化学株式会社 | 2021-08-31 | — | — | CN | disclosed |
| EP-3135681-B1 | RUTHENIUM COMPLEX, METHOD FOR PRODUCING SAME, AND USE OF SAME | TAKASAGO PERFUMERY CO LTD (JP) | 2020-08-19 | — | — | EP | disclosed |
| US-10744494-B2 | Immobilized metal alkylidene catalysts and use thereof in olefin metathesis | XIMO AG (CH) | 2020-08-18 | — | — | US | disclosed |
| EP-3394074-B1 | IMMOBILIZED METAL ALKYLIDENE CATALYSTS AND USE THEREOF IN OLEFIN METATHESIS | XIMO AG (CH) | 2019-10-09 | — | — | EP | disclosed |
| US-6908970-B2 | Process for producing hydrogenated product of cyclic olefin polymer prepared through ring-opening polymerization | ZEON CORPORATION (JP) | 2005-06-21 | — | — | US | disclosed |
| US-6815516-B2 | HEAT RESISTANCE, SOLVENT SOLUBILITY | ZEON CORPORATION (JP) | 2004-11-09 | — | — | US | disclosed |
| US-20030050406-A1 | Process for producing hydrogenated product of cyclic olefin polymer prepared through ring-opening polymerization | ZEON CORPORATION | 2003-03-13 | — | — | US | disclosed |
| US-20030018138-A1 | Copolymer formed by ring -opening polymerization, product of hydrogenation of copolymer formed by ring-opening polymerization, and process for producing these | ZEON CORPORATION (JP) | 2003-01-23 | — | — | US | disclosed |
| EP-1275675-A1 | COPOLYMER FORMED BY RING-OPENING POLYMERIZATION, PRODUCT OF HYDROGENATION OF COPOLYMER FORMED BY RING-OPENING POLYMERIZATION, AND PROCESSES FOR PRODUCING THESE | Zeon Corporation (JP) | 2003-01-15 | — | — | EP | disclosed |
| US-6486264-B1 | Process for producing hydrogenated ring-opening polymerization polymer of cycloolefin | ZEON CORPORATION (JP) | 2002-11-26 | — | — | US | disclosed |
| EP-1197509-A1 | PROCESS FOR PRODUCING HYDROGENATED RING-OPENING POLYMERIZATION POLYMER OF CYCLOOLEFIN | Nippon Zeon Co., Ltd. (JP) | 2002-04-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10744494-B2 | Immobilized metal alkylidene catalysts and use thereof in olefin metathesis | AOC2, AOC3, AOX1 | MEN1 1934/4885KMT2A 573/4885PHGDH 3442/4885 |
| US-20060122398-A1 | Novel nickel-carbene, palladium-carbene and platinum-carbene complexes, their produciton and use in catalytic reactions | PPOX, PDCD1, PDCD1LG2 | MEN1 98/4885KMT2A 2773/4885PHGDH 2181/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.